Natural Alternatives International INC: management transactions · United States · SEC (Form 4)

About Natural Alternatives International INC

Natural Alternatives International, Inc. (NAII) is a U.S.-listed company trading on the Nasdaq market in the United States. Founded in 1980 by Mark LeDoux, the business is headquartered in Carlsbad, California, and has long operated with a bi-national footprint that includes manufacturing capabilities in California and Switzerland. NAII is best understood as a specialized nutrition-platform company rather than a mass-market consumer brand: it serves third-party clients that need formulation, manufacturing, and commercialization support for customized nutritional products. The company’s core activity is private-label and contract manufacturing of vitamins, minerals, herbal products, and other dietary supplements. Its service stack goes beyond toll manufacturing and includes custom formulation, clinical study support, regulatory compliance, international product registration, label-law support, packaging design, scientific research, and marketing assistance. This integrated offering is important competitively because many customers in the nutrition industry want a single partner that can move a product from concept to shelf while managing quality, compliance, and localization across jurisdictions. NAII has also built brand and intellectual-property exposure around CarnoSyn®, its beta-alanine ingredient platform. That ingredient has been central to the company’s sports-nutrition positioning and has been extended into adjacent wellness and healthy-aging applications over time. Historically, the company has invested in product and technology development around beta-alanine delivery formats, including instant-release and sustained-release versions. For investors, that matters because proprietary ingredients can support differentiation, customer stickiness, and licensing or branded-input economics, even when overall contract-manufacturing margins remain under pressure. From a competitive standpoint, NAII occupies a niche in the fragmented nutritional-supplement manufacturing market. Its strengths are science-led formulation, regulatory know-how, and a long operating history; its challenges are typical of the sector, including customer concentration, pricing pressure, raw-material volatility, and the need to maintain quality and compliance across production facilities. The company’s geographic presence in the United States and Switzerland gives it a platform for serving domestic and international clients, which is especially relevant for customers seeking global market access. For SEO and investor context, it is also worth noting that NAII is followed by the market as a small-cap company, which can mean higher share-price sensitivity to earnings releases, contract wins or losses, and insider activity disclosed through SEC Form 4 filings. In February 2026, the company reported fiscal second-quarter results showing net sales of $34.8 million and a net loss of $2.6 million. That recent update reinforces NAII’s profile as an execution-driven niche supplier in the health and nutrition chain, with a business model tied to customized supplement demand, proprietary ingredient value, and regulatory credibility in the United States and abroad.